Heart Disease News and Research

Latest Heart Disease News and Research

LFB completes conversion of all acquired preferred stock

GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire Français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has converted the convertible preferred stock it previously purchased in November 2009 under the terms described in the financing agreements approved by GTC shareholders in July 2009 into a total of 5.3 million shares of common stock.

9 Jan 2010

Type A characteristic associated with reduced job stress

Most characteristics of the "Type A" personality are linked to increased work stress. But there's one important exception, according to a study in the January Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

9 Jan 2010

HRH Princess Haya calls for more investment in medical research

HRH Princess Haya Al Hussein of Jordan yesterday called for more investment in medical research in a keynote speech at a medical conference hosted by the Aswan Heart Centre.

9 Jan 2010

New stem cell therapies to feature at 5th Annual Stem Cell Summit in NYC

Six new stem cell therapies, all forecast to reach physicians in 2010, will be featured at the 5th Annual Stem Cell Summit on February 16 in New York City. These new therapies include allograft products, innovative forms of autologous stem cell technologies, and at least one FDA-approved stem cell drug. New studies showing rehydration of the disc nucleus, regeneration of new heart muscle and others are also on the agenda.

9 Jan 2010

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

Savient Pharmaceuticals, Inc. provided an update on its activities directed toward the resubmission of its Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy and reaffirmed its belief that it continues to be on track for the filing of the BLA resubmission for KRYSTEXXA in the first quarter of 2010.

9 Jan 2010

LehmanMillet honored with four prestigious industry awards

HealthSTAR's LehmanMillet, the leading agency devoted to working with health care companies changing standards of care, today announced it has won four prestigious industry awards: an MM&M (Medical Marketing & Media Magazine) Gold Award for work done on behalf of Abbott Nutrition; a First Place DxMA (Diagnostic Marketing Association) award for work done on behalf of Abbott Diagnostics; a First Place DxMA Award for work done on behalf of BRAHMS USA; and a PM360 Pharma Choice Bronze Award.

9 Jan 2010

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Svelte Medical Systems, Inc. is pleased to announce that it has initiated its European clinical trial at the Thoraxcenter Research Center in Rotterdam, the Netherlands for its “Stent-on-a-Wire” (SOAW) cobalt–chromium Bare Metal Stent.

9 Jan 2010

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

Boston Scientific Corporation announced today that it has received approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its PROMUS® Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The Company plans to launch the product as soon as reimbursement approval is granted, which is expected in the coming weeks.

9 Jan 2010

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has received unconditional approval from the U.S. Food and Drug Administration ("FDA") for the bridge-to-transplant ("BTT") study of the Levacor Ventricular Assist Device ("VAD"). Study enrollment will encompass 160 subjects, a reduction from the approximately 200 subjects of the original statistical plan. As previously announced, the BTT study will begin initially at ten clinical sites.

8 Jan 2010

Health Canada clears Zargis Cardioscan device for sale in Canada

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE), today announced that Health Canada, the Canadian equivalent of the U.S. FDA, has cleared the Zargis Cardioscan(TM) device for sale in Canada.

8 Jan 2010

VA expected to move soon to cover more effects of Agent Orange

The Department of Veterans Affairs may need to pay heavily to treat veterans who have been adversely affected by Agent Orange. McClatchy/Beaufort (S.C.) Gazette report: "The cost of war -- on veterans' health and taxpayer wallets -- will loom a little larger in the new year when the Department of Veterans Affairs issues a final rule to claim adjudicators to presume three more diseases of Vietnam veterans, including heart disease, were caused by exposure to Agent Orange.

8 Jan 2010

Possible loopholes, insurance costs in Senate health bill

"A critical loophole in the current version of the Senate health-care bill would allow insurers to charge more for those who don't participate in wellness programs, essentially negating the measure's key goal of eliminating higher costs for those with pre-existing conditions, a group of health experts said Thursday," MarketWatch reports.

8 Jan 2010

Grubb & Ellis Healthcare REIT II to acquire the Center for Neurosurgery and Spine in Sartell

Grubb & Ellis Healthcare REIT II, Inc. today announced that it has entered into an agreement to acquire the Center for Neurosurgery and Spine, a 36,600-square-foot, two-building medical office portfolio in the St. Cloud suburb of Sartell. The acquisition is subject to customary closing conditions and the satisfaction of other requirements as detailed in the agreement.

8 Jan 2010

Health policy research roundup: Long-term care, diabetes disparities, health IT

Annals of Internal Medicine: Cultural Competency Training and Performance Reports to Improve Diabetes Care for Black Patients - In this study, researchers measure the effects cultural competency training and performance training for physicians has on the clinical outcomes for black patients with diabetes.

8 Jan 2010

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Abbott announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved its XIENCE V® Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease.

8 Jan 2010

Jamba Juice and CAHPERD join to introduce the 2010 Jamba Jump Day event

Jamba Juice Company and The California Association for Health, Physical Education, Recreation and Dance (CAHPERD) announced today its shared mission to keep California's children healthy and active with the 2010 Jamba Jump Day(TM) event -- a mass attempt to break the Guinness World Record for the "Most People Jumping/Skipping Rope at the Same Time".

8 Jan 2010

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

Pharmacogenetics started in the fifties with the discovery of primaquine-related haemolysis among glucose-6-phosphate deshydrogenase deficient patients. At the end of the century, it progressively evolved into Pharmacogenomics, investigating simultaneously multiple gene targets till covering the whole genome in relation with altered drug response.

8 Jan 2010

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Lessons learned from the first 13 children at Johns Hopkins Children's Center to become critically ill from the H1N1 virus show that although all patients survived, serious complications developed quickly, unpredictably, with great variations from patient to patient and with serious need for vigilant monitoring and quick treatment adjustments.

8 Jan 2010

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Autoimmune and autoinflammatory diseases are a major health issue. The National Institutes of Health reports that up to 23.5 million Americans are afflicted. The American Autoimmune Related Diseases Association reports the number is closer to 50 million. Scientists and clinicians at The University of Texas Health Science Center at Houston can address the diagnosis and treatment of these conditions, as well as the latest advances in research.

8 Jan 2010

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Chinese researchers have become the world's fifth most prolific contributors to peer-reviewed scientific literature on clock-reversing regenerative medicine even as a skeptical international research community condemns the practice of Chinese clinics administering unproven stem cell therapies to domestic and foreign patients.

8 Jan 2010

Heart Disease News and Research

Latest Heart Disease News and Research

LFB completes conversion of all acquired preferred stock

Type A characteristic associated with reduced job stress

HRH Princess Haya calls for more investment in medical research

New stem cell therapies to feature at 5th Annual Stem Cell Summit in NYC

Savient Pharmaceuticals announces filing of KRYSTEXXA BLA resubmission on track

LehmanMillet honored with four prestigious industry awards

Svelte Medical Systems initiates European clinical trial for SOAW delivery system

Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System receives Japanese marketing approval

FDA grants unconditional approval for World Heart's Levacor VAD BTT study

Health Canada clears Zargis Cardioscan device for sale in Canada

VA expected to move soon to cover more effects of Agent Orange

Possible loopholes, insurance costs in Senate health bill

Grubb & Ellis Healthcare REIT II to acquire the Center for Neurosurgery and Spine in Sartell

Health policy research roundup: Long-term care, diabetes disparities, health IT

Japanese MHLW approves Abbott's XIENCE V Everolimus Eluting Coronary Stent System

Jamba Juice and CAHPERD join to introduce the 2010 Jamba Jump Day event

ESF-UB Conference to concentrate on potentially clinically relevant polymorphisms

Critically ill children with flu-like symptoms should be treated preemptively with antiviral medications

Scientists and clinicians address diagnosis and treatment for autoimmune and autoinflammatory diseases

Chinese researchers become the world's fifth most prolific contributors to regenerative medicine

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in